Home/Filings/4/0001104659-20-140996
4//SEC Filing

SHALLCROSS STEVEN A 4

Accession 0001104659-20-140996

CIK 0000894158other

Filed

Dec 30, 7:00 PM ET

Accepted

Dec 31, 4:30 PM ET

Size

5.9 KB

Accession

0001104659-20-140996

Insider Transaction Report

Form 4
Period: 2020-12-30
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
  • Award

    Stock Options

    2020-12-30+450,000450,000 total
    Exercise: $0.42From: 2021-01-30Exp: 2027-12-30Common Stock (450,000 underlying)
Footnotes (1)
  • [F1]These stock options will vest pro rata on a monthly basis over 36 months.

Issuer

Synthetic Biologics, Inc.

CIK 0000894158

Entity typeother

Related Parties

1
  • filerCIK 0001263501

Filing Metadata

Form type
4
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 4:30 PM ET
Size
5.9 KB